Are psychological treatments for depression in primary care cost-effective?

Journal of Mental Health Policy and Economics

Volumn 11, Issue 1, 2008, Pages 3-15

  Bosmans, Judith E ^a,b   van Schaik, Digna J F ^a   de Bruijne, Martine C ^a   van Hout, Hein P J ^a   van Marwijk, Harm W J ^a   van Tulder, Maurits W ^a,b   Stalman, Wim A B ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; DESIPRAMINE; DOSULEPIN; FLUOXETINE; LOFEPRAMINE; NORTRIPTYLINE; PAROXETINE;

CINAHL; CLINICAL EFFECTIVENESS; COCHRANE LIBRARY; COGNITIVE THERAPY; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; DEPRESSION; DRUG BLOOD LEVEL; DRUG COST; DRUG DOSE INCREASE; ECONOMIC EVALUATION; EMBASE; HEALTH CARE COST; HEALTH CARE POLICY; HUMAN; HUMAN RELATION; MARITAL THERAPY; MEDLINE; NURSE PRACTITIONER; NURSING CARE; PATIENT CARE; PATIENT COUNSELING; PRIMARY MEDICAL CARE; PSYCHOLOGIST; PSYCHOTHERAPY; PSYCINFO; REVIEW; SYSTEMATIC REVIEW; TREATMENT DURATION;

ADULT; ANTIDEPRESSIVE AGENTS; COST-BENEFIT ANALYSIS; DEPRESSIVE DISORDER; FEMALE; HUMANS; MALE; MIDDLE AGED; PRIMARY HEALTH CARE; PSYCHOTHERAPY;

EID: 42949177994     PISSN: 10914358     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (43)

1. Lepine JP, Gastpar M, Mendlewicz J, Tylee A. Depression in the community: the first pan-European study DEPRES (Depression Research in European Society). Int Clin Psychopharmacol 1997; 12: 19-29.
2. Broadhead WE, Blazer DG, George LK, Tse CK. Depression, disability days, and days lost from work in a prospective epidemiologic survey. JAMA 1990; 264: 2524-2528.
3. Manning WG, Wells KB. The effects of psychological distress and psychological well-being on use of medical services. Med Care 1992; 30: 541-553.
4. Simon GE, VonKorff M, Barlow W. Health care costs of primary care patients with recognized depression. Arch Gen Psychiatry 1995; 52: 850-856.
5. American Psychiatric Association. Practice guideline for the treatment of patients with major depressive disorder (revision). Am J Psychiatry 2000; 157: 1-45.
6. Reesal RT, Lam RW. Clinical guidelines for the treatment of depressive disorders. II. Principles of management. Can J Psychiatry 2001; 46 Suppl 1: 21S-28S.
7. Simon GE. Evidence review: efficacy and effectiveness of antidepressant treatment in primary care. Gen Hosp Psychiatry 2002; 24: 213-224.
8. Williams JW, Mulrow CD, Chiquette E, Noel PH, Aguilar C, Cornell J. A systematic review of newer pharmacotherapies for depression in adults: evidence report summary. Ann Intern Med 2000; 132: 743-756.
9. van Schaik DJ, Klijn AF, van Hout HP, van Marwijk HW, Beekman AT, De Haan M, Van Dyck R. Patients' preferences in the treatment of depressive disorder in primary care. Gen Hosp Psychiatry 2004; 26: 184-189.
10. Bower P, Rowland N. Effectiveness and cost effectiveness of counselling in primary care. Cochrane Database Syst Rev 2006; 3: CD001025.
11. Huibers MJ, Beurskens AJ, Bleijenberg G, van Schayck CP. The effectiveness of psychosocial interventions delivered by general practitioners. Cochrane Database Syst Rev 2003; CD003494.
12. Churchill R, Hunot V, Corney R, Knapp M, McGuire H, Tylee A, Wessely S. A systematic review of controlled trials of the effectiveness and cost- effectiveness of brief psychological treatments for depression. Health Technol Assess 2001; 5: 1-173.
13. Churchill R, Hunot V, Corney R, Knapp M, McGuire H, Tylee A, et al. Brief psychological therapies versus treatment as usual for depression (Protocol). Cochrane Database Syst Rev 2007; Issue 2. Art. No.: CD001763. DOI: 10.1002/14651858.CD001763.pub2.
14. Evers SM, Goossens ME, de Vet HC, van Tulder MW, Ament AJ. Criteria list for assessment of methodological quality of economic evaluations: Consensus on Health Economic Criteria. Int J Technol Assess Health Care 2005; 21: 240-5.
15. Cohen J. Statistical power analysis for the behavioral sciences. Hillsdale, NJ: Lawrence Earlbaum Associates.
16. Organisation for Economic Co-operation and Development. Purchasing Power Parities Data. http://www.oecd.org/document/47/ 0,2340,en_2649_34357_36202863_1_1_1_1,00.html#historicalppp. Last accessed May 29, 2007.
17. U.S.Department of Labor: Bureau of Labor Statistics. Consumer Price Index Home Page. http://www.bls.gov/cpi/. Last accessed May 29, 2007.
18. Cochrane Collaboration. Review Manager 4.2. http://www.cc-ims.net/ RevMan. Last accessed June 29, 2007.
19. Scott AI, Freeman CP. Edinburgh primary care depression study: treatment outcome, patient satisfaction, and cost after 16 weeks. BMJ 1992; 304: 883-7.
20. Lave JR, Frank RG, Schulberg HC, Kamlet MS. Cost-effectiveness of treatments for major depression in primary care practice. Arch Gen Psychiatry 1998; 55: 645-51.
21. Bower P, Byford S, Sibbald B, Ward E, King M, Lloyd M, Gabbay M. Randomised controlled trial of non-directive counselling, cognitive-behaviour therapy, and usual general practitioner care for patients with depression. II: cost effectiveness. BMJ 2000; 321: 1389-92.
22. King M, Sibbald B, Ward E, Bower P, Lloyd M, Gabbay M, Byford S. Randomised controlled trial of non-directive counselling, cognitive-behaviour therapy and usual general practitioner care in the management of depression as well as mixed anxiety and depression in primary care. Health Technol Assess 2000; 4: 1-83.
23. Leff J, Vearnals S, Brewin CR, Wolff G, Alexander B, Asen E, Dayson D, Jones E, Chisholm D, Everitt B. The London Depression Intervention Trial. Randomised controlled trial of antidepressants v. couple therapy in the treatment and maintenance of people with depression living with a partner: clinical outcome and costs. Br J Pychiatry 2000; 177: 95-100.
24. Miller P, Chilvers C, Dewey M, Fielding K, Gretton V, Palmer B, Weller D, Churchill R, Williams I, Bedi N, Duggan C, Lee A, Harrison G. Counseling versus antidepressant therapy for the treatment of mild to moderate depression in primary care: economic analysis. Int J Technol Assess Health Care 2003; 19: 80-90.
25. Simpson S, Corney R, Fitzgerald P, Beecham J. A randomized controlled trial to evaluate the effectiveness and cost-effectiveness of psychodynamic counselling for general practice patients with chronic depression. Psychol Med 2003; 33: 229-239.
26. Simpson S, Corney R, Fitzgerald P, Beecham J. A randomised controlled trial to evaluate the effectiveness and cost-effectiveness of counselling patients with chronic depression. Health Technol Assess 2000; 4: 1-83.
27. Revicki DA, Siddique J, Frank L, Chung JY, Green BL, Krupnick J, Prasad M, Miranda J. Cost-effectiveness of evidence-based pharmacotherapy or cognitive behavior therapy compared with community referral for major depression in predominantly low-income minority women. Arch Gen Psychiatry 2005; 62: 868-875.
28. Drummond MF,. Jefferson TO. Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party. BMJ 1996; 313: 275-283.
29. Drummond MF, Sculpher MJ, Torrance GW, O'Brien BJ, Stoddart GL. Methods for the Economic Evaluation of Health Care Programmes. New York: Oxford University Press, 2005.
30. Gold MR, Siegel JE, Russel LB, Weinstein MC. Cost-Effectiveness in Health and Medicine. New York: Oxford University Press, 1996.
31. Brouwer WB, Koopmanschap MA, Rutten FF. Productivity costs measurement through quality of life? A response to the recommendation of the Washington Panel. Health Econ. 1997; 6: 253-259.
32. Mattke S, Balakrishnan A, Bergamo G, Newberry SJ. A review of methods to measure health-related productivity loss. Am J Manag. Care 2007; 13: 211-217.
33. Sanderson K, Andrews G. Common mental disorders in the workforce: recent findings from descriptive and social epidemiology. Can J Psychiatry 2006; 51: 63-75.
34. Altman DG, Bland JM. Absence of evidence is not evidence of absence. BMJ 1995; 311: 485.
35. Briggs AH, O'Brien BJ. The death of cost-minimization analysis? Health Econ 2001; 10: 179-84.
36. Briggs A. Economic evaluation and clinical trials: size matters. BMJ 2000; 321: 1362-1363.
37. Bower P, Byford S, Barber J, Beecham J, Simpson S, Friedli K, Corney R, King M, Harvey I. Meta-analysis of data on costs from trials of counselling in primary care: using individual patient data to overcome sample size limitations in economic analyses. BMJ 2003; 326: 1247-1250.
38. Von Korff M, Katon W, Bush T, Lin EH, Simon GE, Saunders K, Ludman E, Walker E, Unutzer J. Treatment costs, cost offset, and cost-effectiveness of collaborative management of depression. Psychosom Med 1998; 60: 143-149.
39. Schoenbaum M, Unutzer J, Sherbourne C, Duan N, Rubenstein LV, Miranda J, Meredith LS, Carney MF, Wells K. Cost-effectiveness of practice-initiated quality improvement for depression: results of a randomized controlled trial. JAMA 2001; 286: 1325-1330.
40. Mynors-Wallis L, Davies I, Gray A, Barbour F, Gath D. A randomised controlled trial and cost analysis of problem-solving treatment for emotional disorders given by community nurses in primary care. Br J Psychiatry 1997; 170: 113-119.
41. Schulberg HC, Block MR, Madonia MJ, Scott CP, Rodriguez E, Imber SD, Perel J, Lave J, Houck PR, Coulehan JL. Treating major depression in primary care practice. Eight-month clinical outcomes. Arch Gen Psychiatry 1996; 53: 913-919.
42. Ward E, King M, Lloyd M, Bower P, Sibbald B, Farrelly S, Gabbay M, Tarrier N, Addington-Hall J. Randomized controlled trial of non-directive counselling, cognitive-behaviour therapy, and usual general practitioner care for patients with depression. I: Clinical effectiveness. BMJ 2000; 321: 1383-1388.
43. Chilvers C, Dewey M, Fielding K, Gretton V, Miller P, Palmer B, et al. Antidepressant drugs and generic counselling for treatment of major depression in primary care: randomised trial with patient preference arms. BMJ 2001; 322: 772-775.